How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa

被引:51
|
作者
Terris-Prestholt, Fern [1 ]
Hanson, Kara [1 ]
MacPhail, Catherine [2 ,3 ]
Vickerman, Peter [1 ]
Rees, Helen [2 ]
Watts, Charlotte [1 ]
机构
[1] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England
[2] Wits Reprod Hlth & HIV Inst, Johannesburg, Gauteng, South Africa
[3] Univ New England, Collaborat Res Network Mental Hlth & Wellbeing Ru, Armidale, NSW, Australia
来源
PLOS ONE | 2013年 / 8卷 / 12期
基金
英国医学研究理事会;
关键词
VACCINE ACCEPTABILITY; PREEXPOSURE PROPHYLAXIS; EPIDEMIOLOGIC IMPACT; VAGINAL MICROBICIDES; COST-EFFECTIVENESS; MEN; INFECTION; DIAPHRAGM; GEL; SEX;
D O I
10.1371/journal.pone.0083193
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: For the first time in the history of HIV, new bio-medical interventions have been shown to be effective in preventing HIV transmission. For these new HIV prevention technologies (NPTs) to have an impact on the epidemic, they must be widely used. This study uses a discrete choice experiment (DCE) to: understand the relative strength of women's preferences for product characteristics, understand the implications for substitution away from male condoms, and inform realistic modelling of their potential impact and cost-effectiveness. Methods: A DCE was conducted among 1017 women in urban South Africa. Women were presented with choices between potential women's NPTs (microbicides, diaphragm, female condom) and 'what I did last time' (use or not use a condom) with different HIV and pregnancy prevention effectiveness' and prices. Choice probabilities are estimated using the nested logit model and used to predict uptake. Results: In this high HIV prevalence setting, HIV prevention effectiveness is the main driver of uptake followed by pregnancy prevention effectiveness. For example a microbicide with poor effectiveness would have niche appeal at just 11% predicted uptake, while a highly effective microbicide (95% effective against HIV and pregnancy) would have far wider appeal (56% predicted uptake). Though women who reported not using condoms were more likely to choose the NPTs, at current very high rates of male condom use in South Africa (60%), about half of microbicide uptake is projected to be among those currently not using condoms. Conclusions: Women are very interested in NPTs, especially if highly effective in preventing HIV and pregnancy. Women in greatest need were also most likely to switch to the new products. Where products are not yet available for distribution, proxy data, such as that generated by DCEs, can bring realism to overly optimistic uptake scenarios found in many current impact models.
引用
收藏
页数:13
相关论文
共 20 条
  • [1] Divergent Preferences for HIV Prevention: A Discrete Choice Experiment for Multipurpose HIV Prevention Products in South Africa
    Quaife, Matthew
    Eakle, Robyn
    Escobar, Maria A. Cabrera
    Vickerman, Peter
    Kilbourne-Brook, Maggie
    Mvundura, Mercy
    Delany-Moretlwe, Sinead
    Terris-Prestholt, Fern
    MEDICAL DECISION MAKING, 2018, 38 (01) : 120 - 133
  • [2] Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa
    Minnis, Alexandra M.
    Browne, Erica N.
    Boeri, Marco
    Agot, Kawango
    van der Straten, Ariane
    Ahmed, Khatija
    Weinrib, Rachel
    Mansfield, Carol
    Owino, Frederick
    Manenzhe, Kgahlisho
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 80 (04) : 394 - 403
  • [3] Mapping HIV prevention product preferences among adolescent girls and young women at high risk of HIV: Results from a discrete choice experiment in South Africa
    Malone, S.
    Gomez, A.
    Prasad, R.
    Gangaramany, A.
    Croucamp, Y.
    Kramer, P.
    Mulhausen, J.
    Noble-Campbell, P.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [4] Preferences for Delivery of HIV Prevention Services Among Healthcare Users in South Africa: A Discrete Choice Experiment
    Martin, Catherine Elizabeth
    Blaauw, Duane
    Nongena, Pelisa
    Chidumwa, Glory
    Dada, Siphokazi
    Jack, Samantha
    Butler, Vusile
    Mullick, Saiqa
    AIDS AND BEHAVIOR, 2024, : 331 - 341
  • [5] Coronary heart disease prevention; How much can we expect from cholesterol-lowering therapy?
    Fager, G
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 47 - 47
  • [6] Incorporating end-users' voices into the development of an implant for HIV prevention: a discrete choice experiment in South Africa and Zimbabwe
    Browne, Erica N.
    Manenzhe, Kgahlisho
    Makoni, Wanzirai
    Nkomo, Sikhanyisiwe
    Mahaka, Imelda
    Ahmed, Khatija
    Shapley-Quinn, Mary Kate
    Marton, Tozoe
    Luecke, Ellen
    Johnson, Leah
    van der Straten, Ariane
    Minnis, Alexandra M.
    BMC WOMENS HEALTH, 2023, 23 (01)
  • [7] Incorporating end-users’ voices into the development of an implant for HIV prevention: a discrete choice experiment in South Africa and Zimbabwe
    Erica N. Browne
    Kgahlisho Manenzhe
    Wanzirai Makoni
    Sikhanyisiwe Nkomo
    Imelda Mahaka
    Khatija Ahmed
    Mary Kate Shapley-Quinn
    Tozoe Marton
    Ellen Luecke
    Leah Johnson
    Ariane van der Straten
    Alexandra M. Minnis
    BMC Women's Health, 23
  • [8] Stated preferences for new HIV prevention technologies among men who have sex with men in India: A discrete choice experiment
    Cameron, Michael P.
    Newman, Peter A.
    Chakrapani, Venkatesan
    Shunmugam, Murali
    Roungprakhon, Surachet
    Rawat, Shruta
    Baruah, Dicky
    Nelson, Ruban
    Tepjan, Suchon
    Scarpa, Riccardo
    PLOS ONE, 2024, 19 (07):
  • [9] Couples’ Preferences for “2 in 1” Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe
    Alexandra M. Minnis
    Juliane Etima
    Petina Musara
    Erica N. Browne
    Prisca Mutero
    Doreen Kemigisha
    Nyaradzo M. Mgodi
    Clemensia Nakabiito
    Mary Kate Shapley-Quinn
    Marie C. D. Stoner
    Miriam Hartmann
    Nicole Macagna
    Jeanna Piper
    Ariane van der Straten
    AIDS and Behavior, 2022, 26 : 3848 - 3861
  • [10] Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe
    Minnis, Alexandra M.
    Etima, Juliane
    Musara, Petina
    Browne, Erica N.
    Mutero, Prisca
    Kemigisha, Doreen
    Mgodi, Nyaradzo M.
    Nakabiito, Clemensia
    Shapley-Quinn, Mary Kate
    Stoner, Marie C. D.
    Hartmann, Miriam
    Macagna, Nicole
    Piper, Jeanna
    van der Straten, Ariane
    AIDS AND BEHAVIOR, 2022, 26 (12) : 3848 - 3861